Skip to content
Tirzepatide Report
Provider review

MyDrHank Tirzepatide Review: Starting Prices & Policy Gaps

Researched & written by Alan PierceClinical Pharmacology WriterUpdated

On this page

Named tirzepatide product and landing-page starting prices differ; the complete selected payment remains unconfirmed.

Standout details

  • Actual named product permits public selection between B-12 and glycine formulations
  • Product advertises free consultation and delivery

Things to consider

  • Starting headlines do not establish an independently payable monthly charge
  • The generic cost FAQ and dose-dependent pricing footnote differ

MyDrHank displays “From $240/mo” on its named compounded-tirzepatide product page. Both the selected B-12 formulation and the separately selected glycine formulation showed that starting label. A different public GLP-1 landing page advertises compounded tirzepatide starting at $200/month. These are different published pathways, not a confirmed identical purchase at two prices.3,4

Compare the named offer and its qualifications

The landing page’s pricing footnote says the final amount depends on medication, dose and treatment plan, is subject to medical eligibility and may change. Neither starting headline establishes the full amount collected, supplied period or continuing renewal charge. Obtain those details for the actual formulation and plan before paying.4

The Ivy Rx review raises the same distinction between a shared GLP-1 starting headline and a selected tirzepatide quote. Compare the named medicine, supplied quantity, full first charge and continuing cost before treating either a category price or an every-dose claim as the complete purchase agreement.6

Its expanded cost FAQ says plans start at $171/month, with no contract, physician review, a personalized treatment plan, prescription medication and free shipping. That is a general program answer: the named $171 cards are semaglutide, while the tirzepatide card says $200. The FAQ also says pricing stays the same at every dose, which conflicts with the dose-dependent pricing footnote. Do not assume a guaranteed flat tirzepatide price.4

MyDrHank: compare the published starting prices

Published detailDecision before payment
B-12 product selectedFrom $240/month; full charge and term not established.
Glycine product selectedAlso from $240/month; not a confirmed all-dose bill.
Named tirzepatide landing cardStarting $200/month, subject to dose, plan and eligibility.
General cost FAQStarts $171/month; not the named tirzepatide card price.
Named product and landing-page prices have different scopes; the landing FAQ and dose-dependent footnote also differ.3,4

Get the financial terms before authorizing payment

The product page advertises free consultation and delivery. The landing page says “cancel anytime,” and its FAQ says “no contract.” Those statements do not establish a refund right, renewal-processing deadline or what happens after medical review, prescription preparation or shipment.3,4

The altRX review examines the written subscription and refund conditions behind another cancel-anytime offer. Compare the notice requirement and payment-finality rule, rather than assuming the same slogan produces the same exit rights.

The AbundRx review shows why billing and shipping need separate deadlines: its policy asks for 72 hours before the next bill and separately allows a refund request when an order has not shipped within 14 days. Those are AbundRx’s rules; ask MyDrHank for the cancellation cutoff and shipment remedy attached to its own offer.

The public Terms reviewed do not set out a refund, cancellation, renewal or billing schedule. That limited public information does not establish that every purchase is refundable or that no further agreement applies. Request the agreement for the selected purchase, including any retained consultation charge, nonapproval outcome and treatment of unused paid time.5

MyDrHank: questions before committing

Published detailDecision before payment
Included-service claimsProduct: free consultation/delivery; general FAQ also includes medication.
Dose pricing discrepancyFAQ says flat at every dose; footnote says dose-dependent.
Cancellation and refundsNo contract/cancel-anytime claims do not specify a refund or cutoff.
Payment and nonapprovalObtain full charge, future schedule and written declined-treatment outcome.
Public marketing does not establish the financial agreement for a selected purchase.3,4,5

Understand the platform and pharmacy roles

The Terms identify Dr. Hank, LLC and say using its platform does not create a provider-patient relationship with Dr. Hank. They describe pharmacy partners generically, with a current list available on request, and do not guarantee a prescription. This does not identify the facility dispensing an individual order or independently establish licensing, accreditation or 503 classification.5

Ask for the actual prescriber, dispensing contact, formulation and supplied quantity. The B-12 and glycine options identify different compounded formulations; their product descriptions do not establish an added clinical benefit for an individual patient. The SURMOUNT trials studied specific products and treatment protocols; their findings do not establish equivalent results for these compounded formulations.1,2

Further reading

AbundRx review · AltRx review · Ascend Vitality review · Compare tirzepatide providers · BMI MD review · Compounded tirzepatide: legal status · Tirzepatide research guide · Gallbladder risks · Thyroid cancer warning · Zepbound side effects

Frequently asked questions

Why does MyDrHank show both $200 and $240 for tirzepatide?

The named product shows from $240/month with either B-12 or glycine selected. A separate landing card starts at $200/month and qualifies pricing by medication, dose, plan and eligibility. The pages do not establish identical purchases or full collected charges.

Is $171 the tirzepatide price, and does every dose cost the same?

The $171 figure is a general FAQ starting price and appears on named semaglutide cards. Tirzepatide starts at $200 on that landing page. Its flat-dose FAQ wording conflicts with a dose-dependent pricing footnote, so confirm the selected plan in writing.

Does cancel anytime mean I receive a refund?

The public marketing does not establish a refund right, renewal cutoff or nonapproval outcome. The reviewed Terms do not state a financial schedule. Obtain the selected-purchase agreement and written cancellation confirmation.

References(6)

  1. Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, Kiyosue A, Zhang S, Liu B, Bunck MC, Stefanski A, and the SURMOUNT-1 Investigators (2022). Tirzepatide Once Weekly for the Treatment of Obesity.. New England Journal of Medicine. PMID: 35658024. Read source
  2. Aronne LJ, Horn DB, le Roux CW, Ho W, Falcon BL, Bays HE, et al. (2025). Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5).. New England Journal of Medicine. PMID: 40353578. Read source
  3. MyDrHank (2026). Compounded tirzepatide: public product and plan options. MyDrHank.
  4. MyDrHank (2026). Public GLP-1 landing page: starting offer and conditions. MyDrHank.
  5. MyDrHank (2026). Terms of Use: platform and pharmacy roles. MyDrHank.
  6. Ivy Rx (2026). Personalized GLP-1 injections: shared starting headline and named ingredients. Ivy Rx.

About the author

Alan Pierce

Clinical Pharmacology Writer

About Tirzepatide Report · How we verify prices

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.